Eltzschig et al., 2009 - Google Patents
Central role of Sp1-regulated CD39 in hypoxia/ischemia protectionEltzschig et al., 2009
View HTML- Document ID
- 13861599564497907280
- Author
- Eltzschig H
- Köhler D
- Eckle T
- Kong T
- Robson S
- Colgan S
- Publication year
- Publication venue
- Blood, The Journal of the American Society of Hematology
External Links
Snippet
Hypoxia is common to several inflammatory diseases, where multiple cell types release adenine-nucleotides (particularly adenosine triphosphate/adenosine diphosphate). Adenosine triphosphate/adenosine diphosphate is metabolized to adenosine through a 2 …
- 206010021143 Hypoxia 0 title abstract description 80
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Eltzschig et al. | Central role of Sp1-regulated CD39 in hypoxia/ischemia protection | |
Morote-Garcia et al. | HIF-1–dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak | |
Morote–Garcia et al. | Hypoxia-inducible factor–dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia | |
Eltzschig et al. | HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia | |
Chen et al. | Akt isoforms differentially regulate neutrophil functions | |
Liu et al. | Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression | |
Feoktistov et al. | Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype | |
Eckle et al. | Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury | |
Eltzschig et al. | Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors | |
Li et al. | Activation of the AMPK-FOXO3 pathway reduces fatty acid–induced increase in intracellular reactive oxygen species by upregulating thioredoxin | |
Li et al. | PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling | |
Hart et al. | SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning | |
Kim et al. | Klotho may ameliorate proteinuria by targeting TRPC6 channels in podocytes | |
Eckle et al. | A2B adenosine receptor dampens hypoxia-induced vascular leak | |
Abell et al. | Stat3-induced apoptosis requires a molecular switch in PI (3) K subunit composition | |
Chi et al. | Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy | |
Huang et al. | Convergence of G protein–coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injury | |
Westermeier et al. | Insulin restores gestational diabetes mellitus–reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium | |
Black et al. | Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension | |
Zheng et al. | Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium | |
Lee et al. | A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis | |
Grenz et al. | Partial netrin-1 deficiency aggravates acute kidney injury | |
Edwards et al. | RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia | |
Koeppen et al. | Interplay of hypoxia and A2B adenosine receptors in tissue protection | |
Jiang et al. | Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity |